RIP3 inhibits inflammatory hepatocarcinogenesis but promotes cholestasis by controlling caspase-8- and JNK-dependent compensatory cell proliferation - Vucur, M; Reisinger, F; Gautheron, J (Cell Reports, 2013)
, et al.